Related Experiment Video
Updated: Jun 24, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Role of thrombectomy in acute myocardial infarction
Manesh Thomas1, Kanak Das, Aravinda Nanjundappa
1Department of Internal Medicine: Cardiology, University of Tennessee Health Science Center, Memphis, TN 38104, USA. mthoma40@utmem.edu
Insights
Thrombectomy devices may help reduce clot burden in acute ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention. However, current evidence from randomized trials is conflicting, requiring further investigation into their role.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Background:
- Acute ST-elevation myocardial infarction (STEMI) is caused by coronary artery occlusion due to thrombus.
- Reperfusion therapy aims to minimize mechanical obstruction and restore blood flow.
- Primary percutaneous coronary intervention (PCI) is preferred over thrombolysis if timely reperfusion is achieved.
Purpose of the Study:
- To evaluate the potential role of thrombectomy devices as an adjunct to PCI in STEMI treatment.
- To analyze the effectiveness of reducing thrombus burden in acute myocardial infarction.
Main Methods:
- Review of randomized clinical trials investigating thrombectomy devices in STEMI.
- Analysis of studies comparing thrombectomy adjunct to PCI versus PCI alone.
- Examination of variable clinical endpoints and conflicting results from existing trials.
Main Results:
- Several thrombectomy devices have been studied in STEMI patients undergoing PCI.
- Randomized clinical trials have yielded conflicting results regarding the benefit of thrombectomy.
- Definitive conclusions on the efficacy and optimal use of thrombectomy devices are lacking.
Conclusions:
- Reducing thrombus burden with devices during PCI for STEMI is an attractive therapeutic concept.
- Further research is needed to clarify the definitive role and clinical utility of thrombectomy in acute myocardial infarction management.
Abstract:
Acute ST elevation myocardial infarction results from atherosclerotic plaque rupture with subsequent thrombus formation, leading to complete or near complete occlusion of an epicardial coronary artery. Minimization of the mechanical obstruction from this thrombus remains the main goal of therapy in ST elevation myocardial infarction. Primary percutaneous coronary intervention for an ST elevation myocardial infarction appears to be the preferred mode of revascularization over thrombolytic therapy if the door-to-balloon time target of 90 min is achievable. The idea of reducing the thrombus burden with the use of devices as an adjunct to percutaneous coronary intervention is an attractive one. Several thrombectomy devices have been studied in randomized clinical trials, but no definitive conclusions have emerged, owing to conflicting results and variable clinical end points. This article intends to shed further light on the potential role of thrombectomy in the treatment of acute myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction

